Actuate Therapeutics
Pre-clinicalWe aim to give patients the opportunity to live longer and better. Learn more about our lead drug, elraglusib.
Founded
2015
Focus
Small Molecules
About
We aim to give patients the opportunity to live longer and better. Learn more about our lead drug, elraglusib.
Funding History
3Total raised: $40M
Series B$25MRiverVest Venture PartnersJul 15, 2021
Series A$12MBios PartnersOct 15, 2018
Seed$3MUndisclosedJun 15, 2016
Company Info
TypePrivate
Founded2015
LocationFort Worth, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile